Lacticaseibacillus parahuelsenbergensis THGS-36 alleviates acne-like inflammation and lipogenesis in sebocytes via CREB signaling
Life Sciences · 2026-09 · 400 · 124497
DOI: 10.1016/j.lfs.2026.124497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-09. Verfasst von Qiwen Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biotechnology, Kyung Hee University, Yongin, 17104, Republic of Korea. Hauptthemen laut MEDLINE: Lipogenesis, Acne Vulgaris, Inflammation, Cyclic AMP Response Element-Binding Protein. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Acne vulgaris is a chronic inflammatory disorder of the pilosebaceous unit and is associated with Cutibacterium acnes overgrowth, excessive sebum production, and persistent inflammatory responses. This study evaluated the anti-acne potential of the cell-free supernatant (CFS) from Lacticaseibacillus parahuelsenbergensis THGS-36 and investigated its host-modulatory effects in sebocytes with a focus on CREB-associated signaling. THGS-36 CFS exhibited dose-dependent antibacterial activity against C. acnes strains KACC 11946 and KACC 19884, with identical minimum inhibitory concentration and minimum bactericidal concentration values of 1.25 mg/mL, and inhibited biofilm formation beginning at a sub-inhibitory concentration. In human sebocytes, 50 μg/mL THGS-36 CFS reduced C. acnes adhesion by 17.2% and significantly suppressed C. acnes CFS-induced secretion of IL-1β, IL-6, IL-8, and TNF-α, concomitant with reduced expression of TLR2 and NFKBIA, as well as decreased phosphorylation of IκBα and p65, indicating attenuation of NF-κB signaling. Under IGF-1 stimulation, THGS-36 CFS decreased lipid accumulation and downregulated lipogenesis-associated transcripts, including SREBF1, FASN, and PPARG. Mechanistically, the anti-inflammatory and anti-lipogenic effects of THGS-36 CFS were associated with stimulus-dependent modulation of CREB phosphorylation. Whole-genome sequencing supported the safety profile of THGS-36 by revealing no detectable virulence- or antibiotic resistance-associated determinants and identifying putative class II bacteriocin gene clusters. Collectively, THGS-36 CFS exerts multi-target anti-acne activity by inhibiting C. acnes growth and biofilm formation while attenuating sebocyte inflammation and lipogenesis, supporting its potential as a safe adjuvant or alternative strategy for acne treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Biotechnology, Kyung Hee University, Yongin, 17104, Republic of Korea.
- Department of Convergent Biotechnology and Advanced Materials Engineering, Graduate School, Kyung Hee University, Yongin, 17104, Republic of Korea.
- Institute of Life Sciences & Resources and Department of Food Science & Biotechnology, Kyung Hee University, Yongin, 17104, Republic of Korea.
- Institute of Life Sciences & Resources and Department of Food Science & Biotechnology, Kyung Hee University, Yongin, 17104, Republic of Korea. Electronic address: mijukim@khu.ac.kr.
- Graduate School of Biotechnology, Kyung Hee University, Yongin, 17104, Republic of Korea. Electronic address: drhoo@khu.ac.kr.
Zitieren
APA
Zheng, Q., Yi, G. S., Bae, C. I., Kim, S., Nguyen, T. T. M., Kim, J. W., Kim, M. J., & Yi, T. H. (2026). Lacticaseibacillus parahuelsenbergensis THGS-36 alleviates acne-like inflammation and lipogenesis in sebocytes via CREB signaling. Life Sciences, 400, 124497. https://doi.org/10.1016/j.lfs.2026.124497
Vancouver
Zheng Q, Yi GS, Bae CI, Kim S, Nguyen TTM, Kim JW, et al. Lacticaseibacillus parahuelsenbergensis THGS-36 alleviates acne-like inflammation and lipogenesis in sebocytes via CREB signaling. Life Sciences. 2026;400:124497. doi:10.1016/j.lfs.2026.124497
BibTeX
@article{Zheng2026,
author = {Zheng, Qiwen and Yi, Gyeong-Seon and Bae, Chan-Il and Kim, Somyeong and Nguyen, Trang Thi Minh and Kim, Jae-Woo and Kim, Mi-Ju and Yi, Tae-Hoo},
title = {Lacticaseibacillus parahuelsenbergensis THGS-36 alleviates acne-like inflammation and lipogenesis in sebocytes via CREB signaling},
journal = {Life Sciences},
year = {2026},
volume = {400},
pages = {124497},
doi = {10.1016/j.lfs.2026.124497}
}
EUVIMED